Literature DB >> 18806349

Risk factors for SARS infection within hospitals in Hanoi, Vietnam.

Ayako Nishiyama1, Naomi Wakasugi, Teruo Kirikae, Tran Quy, Le Dang Ha, Vo Van Ban, Hoang Thuy Long, Naoto Keicho, Takehiko Sasazuki, Tadatoshi Kuratsuji.   

Abstract

We investigated a nosocomial infection of severe acute respiratory syndrome (SARS) in Vietnam in 2003 and attempted to identify risk factors for SARS infection. Of the 146 subjects who came into contact with SARS patients at Hospital A, 43 (29.5%) developed SARS, and an additional 16 (11%) were asymptomatic but SARS-coronavirus (CoV) seropositive. The asymptomatic infection rate accounted for 15.5% of the total number of infected patients at Hospital A, which was higher than that of 6.5% observed at Hospital B, to where all patients from Hospital A were eventually transported (P<0.05). At Hospital A, the risk for developing SARS was 12.6 times higher in individuals not using a mask than in those using a mask. The SARS epidemic in Vietnam resulted in numerous secondary infections due to its unknown etiology and delayed recognition at the beginning of the epidemic. The consistent and proper use of a mask was shown to be crucial for constant protection against infection with SARS.

Entities:  

Mesh:

Year:  2008        PMID: 18806349

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  25 in total

1.  Associations Between Wearing Masks and Respiratory Viral Infections: A Meta-Analysis and Systematic Review.

Authors:  Yiming Chen; Yuelin Wang; Ningbin Quan; Jun Yang; Yinyin Wu
Journal:  Front Public Health       Date:  2022-04-27

2.  Behavioural responses to influenza pandemics: what do we know?

Authors:  Marta Balinska; Caterina Rizzo
Journal:  PLoS Curr       Date:  2009-09-09

Review 3.  The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence.

Authors:  Faisal Bin-Reza; Vicente Lopez Chavarrias; Angus Nicoll; Mary E Chamberland
Journal:  Influenza Other Respir Viruses       Date:  2011-12-21       Impact factor: 4.380

Review 4.  Strategy and technology to prevent hospital-acquired infections: Lessons from SARS, Ebola, and MERS in Asia and West Africa.

Authors:  Sanjeewa Jayachandra Rajakaruna; Wen-Bin Liu; Yi-Bo Ding; Guang-Wen Cao
Journal:  Mil Med Res       Date:  2017-10-27

5.  Socioeconomic and Behavioral Correlates of COVID-19 Infections among Hospital Workers in the Greater Jakarta Area, Indonesia: A Cross-Sectional Study.

Authors:  Adrianna Bella; Mochamad Thoriq Akbar; Gita Kusnadi; Olivia Herlinda; Putri Aprilia Regita; Dian Kusuma
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

Review 6.  The emergence of the Middle East respiratory syndrome coronavirus.

Authors:  Shauna Milne-Price; Kerri L Miazgowicz; Vincent J Munster
Journal:  Pathog Dis       Date:  2014-04-09       Impact factor: 3.166

7.  Cost-effectiveness analysis of N95 respirators and medical masks to protect healthcare workers in China from respiratory infections.

Authors:  Shohini Mukerji; C Raina MacIntyre; Holly Seale; Quanyi Wang; Peng Yang; Xiaoli Wang; Anthony T Newall
Journal:  BMC Infect Dis       Date:  2017-07-03       Impact factor: 3.090

Review 8.  Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review.

Authors:  Roger Chou; Tracy Dana; David I Buckley; Shelley Selph; Rongwei Fu; Annette M Totten
Journal:  Ann Intern Med       Date:  2020-05-05       Impact factor: 51.598

Review 9.  Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings : A Living Rapid Review.

Authors:  Roger Chou; Tracy Dana; Rebecca Jungbauer; Chandler Weeks; Marian S McDonagh
Journal:  Ann Intern Med       Date:  2020-06-24       Impact factor: 51.598

Review 10.  Environmental and decontamination issues for human coronaviruses and their potential surrogates.

Authors:  Nevio Cimolai
Journal:  J Med Virol       Date:  2020-07-02       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.